Lucigen
Molecular point-of-care detection of infectious disease - as sensitive as central lab tests and as fast & inexpensive as rapid antigen tests
- Stage $3M in TTM Revenue
- Industry Medical Devices and Equipment
- Location Middleton, WI, USA
- Currency USD
- Founded January 1998
- Employees 35
- Website lucigen.com
Company Summary
Lucigen is a successful life sciences/research tools company in the molecular biology arena. We are highly-regarded for our cloning, phage display, protein engineering and enzyme discovery. Amongst our customers are leading companies such as Novartis, Pfizer and Life Technologies. Lucigen has been profitable and cash-flow positive since 2007. We are seeking to enter the clinical diagnostics space, leveraging our patented PyroScript(R) enzyme.
Team
-
David Mead, Ph.D.CEO and Founder
-
Jeff Williams, Ph.D.President
-
Andy ShragoVP, Business Development
-
Ralph KautenChairman of the Board
Advisors
-
DeWitt, Ross & StephensLawyerUnconfirmedSmith & GestelandAccountantUnconfirmed
Previous Investors
-
100% Angel FundedUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.